| Application no. and date | 18204763.9 (espacenet) (Federated) (European Patent Register), 20181106 | | Patent/reg. no. and date | DK/EP 3498297, 20230621 | | Publication date | 20190619 | | Priority no. and date | US 201762582141 P, 20171106, EP 17200219, 20171106, EP 18169952, 20180427, US 201862663647 P, 20180427 | | EP pub. no. and date |
EP 3498297 20190619 | | Effective date | | | Applicant/owner | Stalicla S.A., Avenue de Sécheron 15
1202 Geneva, CH | | Applicant ref. no. | | | Inventor | Durham, Lynn, STALICLA SA
Avenue de Sécheron 15
1202 Genève, CH | | Representative | | | Opponent | | | IPC Class | A61K 45/00 (2006.01) , A61P 25/00 (2006.01) | | Title | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
